Risk factors for hyperglycemia in children with leukemia receiving l-asparaginase and prednisone

Ching Hon Pui, George A. Burghen, W. Paul Bowman, Rhomes J.A. Aur

Research output: Contribution to journalArticle

87 Citations (Scopus)

Abstract

We determined retrospectively the frequency and risk of hyperglycemia in 421 children with leukemia who had received l-asparaginase and prednisone as part of their remission induction therapy. Forty-one patients (9.7%) developed this complication, 39 within one week after the first dose of l-asparaginase. Hyperglycemia resolved in all patients and in 32 before the end of the four-week induction period. Age, obesity, and Down syndrome each had a significant bearing on the frequency of hyperglycemia. Children 10 years of age or older were more likely to develop the complication than were younger children. When more than one factor was present in a child, the risk of hyperglycemia increased significantly. A family history of diabetes mellitus also appeared related to an increased risk of hyperglycemia. Childhood leukemia patients with any of the risk factors identified here should be closely monitored for glucosuria while receiving prednisone and l-asparaginase for remission induction.

Original languageEnglish
Pages (from-to)46-50
Number of pages5
JournalThe Journal of Pediatrics
Volume99
Issue number1
DOIs
StatePublished - Jul 1981

Fingerprint

Asparaginase
Prednisone
Hyperglycemia
Leukemia
Remission Induction
Down Syndrome
Diabetes Mellitus
Obesity

Cite this

Pui, Ching Hon ; Burghen, George A. ; Bowman, W. Paul ; Aur, Rhomes J.A. / Risk factors for hyperglycemia in children with leukemia receiving l-asparaginase and prednisone. In: The Journal of Pediatrics. 1981 ; Vol. 99, No. 1. pp. 46-50.
@article{3b447f045917491aaee34ca41ba42257,
title = "Risk factors for hyperglycemia in children with leukemia receiving l-asparaginase and prednisone",
abstract = "We determined retrospectively the frequency and risk of hyperglycemia in 421 children with leukemia who had received l-asparaginase and prednisone as part of their remission induction therapy. Forty-one patients (9.7{\%}) developed this complication, 39 within one week after the first dose of l-asparaginase. Hyperglycemia resolved in all patients and in 32 before the end of the four-week induction period. Age, obesity, and Down syndrome each had a significant bearing on the frequency of hyperglycemia. Children 10 years of age or older were more likely to develop the complication than were younger children. When more than one factor was present in a child, the risk of hyperglycemia increased significantly. A family history of diabetes mellitus also appeared related to an increased risk of hyperglycemia. Childhood leukemia patients with any of the risk factors identified here should be closely monitored for glucosuria while receiving prednisone and l-asparaginase for remission induction.",
author = "Pui, {Ching Hon} and Burghen, {George A.} and Bowman, {W. Paul} and Aur, {Rhomes J.A.}",
year = "1981",
month = "7",
doi = "10.1016/S0022-3476(81)80955-9",
language = "English",
volume = "99",
pages = "46--50",
journal = "The Journal of Pediatrics",
issn = "0022-3476",
publisher = "Mosby Inc.",
number = "1",

}

Risk factors for hyperglycemia in children with leukemia receiving l-asparaginase and prednisone. / Pui, Ching Hon; Burghen, George A.; Bowman, W. Paul; Aur, Rhomes J.A.

In: The Journal of Pediatrics, Vol. 99, No. 1, 07.1981, p. 46-50.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Risk factors for hyperglycemia in children with leukemia receiving l-asparaginase and prednisone

AU - Pui, Ching Hon

AU - Burghen, George A.

AU - Bowman, W. Paul

AU - Aur, Rhomes J.A.

PY - 1981/7

Y1 - 1981/7

N2 - We determined retrospectively the frequency and risk of hyperglycemia in 421 children with leukemia who had received l-asparaginase and prednisone as part of their remission induction therapy. Forty-one patients (9.7%) developed this complication, 39 within one week after the first dose of l-asparaginase. Hyperglycemia resolved in all patients and in 32 before the end of the four-week induction period. Age, obesity, and Down syndrome each had a significant bearing on the frequency of hyperglycemia. Children 10 years of age or older were more likely to develop the complication than were younger children. When more than one factor was present in a child, the risk of hyperglycemia increased significantly. A family history of diabetes mellitus also appeared related to an increased risk of hyperglycemia. Childhood leukemia patients with any of the risk factors identified here should be closely monitored for glucosuria while receiving prednisone and l-asparaginase for remission induction.

AB - We determined retrospectively the frequency and risk of hyperglycemia in 421 children with leukemia who had received l-asparaginase and prednisone as part of their remission induction therapy. Forty-one patients (9.7%) developed this complication, 39 within one week after the first dose of l-asparaginase. Hyperglycemia resolved in all patients and in 32 before the end of the four-week induction period. Age, obesity, and Down syndrome each had a significant bearing on the frequency of hyperglycemia. Children 10 years of age or older were more likely to develop the complication than were younger children. When more than one factor was present in a child, the risk of hyperglycemia increased significantly. A family history of diabetes mellitus also appeared related to an increased risk of hyperglycemia. Childhood leukemia patients with any of the risk factors identified here should be closely monitored for glucosuria while receiving prednisone and l-asparaginase for remission induction.

UR - http://www.scopus.com/inward/record.url?scp=0019456878&partnerID=8YFLogxK

U2 - 10.1016/S0022-3476(81)80955-9

DO - 10.1016/S0022-3476(81)80955-9

M3 - Article

C2 - 6454771

AN - SCOPUS:0019456878

VL - 99

SP - 46

EP - 50

JO - The Journal of Pediatrics

JF - The Journal of Pediatrics

SN - 0022-3476

IS - 1

ER -